JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Right arrow Help viewing high resolution images
Right arrow Return to article
Click on image to view larger version.


Figure 3


FIGURE 3.  18F-FDG uptake in bone marrow (A) and spleen (B) in patients (n = 16) at baseline and after single doses of adjuvant pegfilgrastim (scan 2). Average SULmean in bone marrow and spleen is significantly higher on scan 2 (P < 0.0001).





Right arrow Return to article


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE